Exosome Therapy
Cell-derived nanoparticles containing bioactive molecules that may provide regenerative benefits similar to stem cells.
Evidence Summary
Active research area with promising preclinical results. Human evidence limited. May offer advantages over stem cells for manufacturing and safety. Regulatory landscape evolving.
Evidence Scale
Mechanism of Action
Exosomes carry proteins, lipids, and nucleic acids that modulate recipient cell function. May provide paracrine benefits of stem cells without cell transplantation.
Who Is This For?
Regenerative goals, anti-aging, tissue healing. Experimental with limited proven applications.
Protocol & Dosing
Dose
Varies by source and indication. Typical: 10-50 billion exosomes per treatment.
Frequency
Single to monthly
Duration
Variable protocols
Protocol Summary
IV infusion or local injection of purified exosomes. Source and processing critical. Various origin types (MSC, placental, etc.).
Interactions & Precautions
Contraindications
- Active infection
- Active malignancy (theoretical)
Potential Risks
- •Limited human data
- •Quality control challenges
- •Regulatory uncertainty
- •Unknown long-term effects
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Promising but early. Source and manufacturing quality critical. May eventually replace some stem cell applications. Research rapidly evolving.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$$$$
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation